
PMPM, Per-Seat, or Outcomes-Based: How to Actually Price a Health AI Product
Dr. Dereck Mush, MD, MBASmithRx is a pharmacy benefit manager that runs drug benefits for employers on a fixed fee basis and passes all rebates and discounts back to clients.
SmithRx was founded in 2016 and is based in San Francisco. Founder and CEO Jake Frenz previously worked at Collective Health and Anthem. The company manages prescription drug benefits for self insured employers and health plans, charging an administrative fee instead of earning spread pricing, and passing 100 percent of rebates through to the plan sponsor. Its programs include Autoimmune Savings and Low Cost Insulin, and it has partnered with Mark Cuban Cost Plus Drug Company and Amazon Pharmacy. SmithRx raised a $20 million Series B in 2022 and a $60 million Series C in January 2024, both led by Venrock.
Leadership as of 14 November 2026.
Founder and CEO

Dr. Dereck Mush, MD, MBARelated companies